All In Biotech

Drug Trial Radar · NCT00512317

Open-label Extension to Protocol 1042-0600

An Open-label Extension Study to Evaluate the Safety, Tolerability, and Efficacy of Ganaxolone as add-on Therapy in Adult Patients With Epilepsy Consisting of Uncontrolled Partial-onset Seizures.

Last checked: Nov 19, 2026Latest source record: Jan 17, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

123

Actual

Start

Jun 2007

Primary completion

Dec 2009

Study completion Sep 2013

Sponsor

Lead sponsor
Marinus PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Aug 7, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 69 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To allow open-label extension to patients who have completed Protocol 1042-0600.

Conditions

  • Epilepsies, Partial

Interventions

  • ganaxoloneDrug

    liquid suspension dosed tid

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent Change From Baseline in Weekly Seizure Frequency During Weeks 1 Through 117Time frame: Baseline (Day 0) and Week 1 through Week 117

Locations

25 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama

    Birmingham, Alabama

  • Barrow Neurological Institute

    Phoenix, Arizona

  • Arkansas Epilepsy Program

    Little Rock, Arkansas

  • University of Southern California Adult Comprehensive Epilepsy Center

    Los Angeles, California

  • University of California-Davis

    Sacramento, California

  • Anchutz Outpatient Pavillion Neurosciences Clinic/ University of Colorado Hospital

    Aurora, Colorado

  • Yale University School of Medicine

    New Haven, Connecticut

  • University of Florida McKnight Brain Institute

    Gainesville, Florida

  • Intercoastal Neurology

    Sarasota, Florida

  • Emory HealthCare

    Atlanta, Georgia

  • Southern Illinois University Medical Center

    Springfield, Illinois

  • University of Iowa Hospitals and Clinics

    Iowa City, Iowa

  • University of Kentucky, Dept. of Neurology

    Lexington, Kentucky

  • Mid-Atlantic Epilepsy and Sleep Center

    Bethesda, Maryland

  • 2799 West Grand blvd. CFP 071

    Detroit, Michigan

  • Minnesota Epilepsy Group, PA

    Saint Paul, Minnesota

  • Comprehensive Epilepsy Care Center for Children and Adults

    Chesterfield, Missouri

  • Neurosciences Institute at Albany Medical Center

    Albany, New York

  • SUNY Upstate Medical University

    Syracuse, New York

  • Ohio State University Medical Center

    Columbus, Ohio

  • Riddle Health Care Center for Neuroscience

    Media, Pennsylvania

  • Thomas Jefferson University

    Philadelphia, Pennsylvania

  • Vanderbilt University Medical Center

    Nashville, Tennessee

  • Neurological Clinic of Texas, P.A.

    Dallas, Texas

  • Virginia Commonwealth University

    Richmond, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.